Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

AAN Guideline: MRIs help diagnose multiple sclerosis faster

09.09.2003


Using MRI scans can help make the diagnosis of multiple sclerosis (MS) more quickly, according to a guideline developed by the American Academy of Neurology. The guideline is published in the September 9 issue of Neurology, the scientific journal of the American Academy of Neurology.



The point at which MS can be diagnosed has been under debate, according to guideline author Elliot Frohman, MD, PhD, of the University of Texas Southwestern Medical School in Dallas.

"Before, the criteria used to diagnosis people required neurologists to show that disease activity had occurred in the brain over time," said Frohman. "People would have to wait for a diagnosis. Now that we have evidence showing that early treatment can reduce the entire course of the disease, we really needed to ask the question about how early the diagnosis can be made."


To develop the guideline, the researchers evaluated all of the scientific studies on the topic. They determined that in many cases findings on a single MRI of the brain and spinal cord can be a strong indicator of whether someone will develop MS in the future. The guideline addresses cases where a young to middle-aged adult has a single occurrence of a sign or symptom of MS activity and other possible diagnoses have been ruled out.

MS involves inflammation of the brain and spinal cord. This inflammation leads to lesions, or areas of damage, on the brain and spinal cord. The guidelines outline the number and type of these lesions that, if present, are a strong predictor of the future development of clinically definite MS. For example, a patient with three or more lesions in the white matter area of the brain has a greater than 80-percent likelihood of developing MS within the next seven to 10 years.

"This guideline helps us use MRI to telescope into the future to see what’s going to happen with these patients," Frohman said. "The evidence allows us to predict with more certainty who will develop MS, which allows us to begin helpful treatment earlier than in the past."

Evidence shows that early treatment of MS can lessen the disease activity and severity. There is also evidence that, if untreated in the early stages, the disease can accelerate and may even become resistant to treatment, Frohman said.

"With this knowledge and the fact that the current drugs for MS have few downsides except for cost and minor side effects, there’s not much sense in waiting for more disability and more attacks to occur," he said.

The criteria currently used for diagnosis are not sensitive enough to identify many patients who already have MS at the time of their first attack, Frohman said. The current criteria recommend waiting for additional signs of disease activity before making the diagnosis of MS.

"In some ways, that’s like waiting for the other shoe to drop," he said. "If the majority of these patients have MS and waiting could compromise how we can affect the course of the disease, then we need to go ahead and treat them."

The guideline notes that neurologists must consider MRI information in the context of each patient’s specific situation.



The American Academy of Neurology, an association of more than 18,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as stroke, Alzheimer’s disease, epilepsy, Parkinson’s disease, autism and multiple sclerosis.

For more information about the American Academy of Neurology, visit its web site at http://www.aan.com.

Marilee Reu | AAN
Further information:
http://www.aan.com

More articles from Health and Medicine:

nachricht PET imaging tracks Zika virus infection, disease progression in mouse model
20.09.2017 | US Army Medical Research Institute of Infectious Diseases

nachricht 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Molecular Force Sensors

20.09.2017 | Life Sciences

Producing electricity during flight

20.09.2017 | Power and Electrical Engineering

Tiny lasers from a gallery of whispers

20.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>